CITADEL ADVISORS LLC

Holdings History for Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM)

Symbol: ADVM
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025			-0%	$0	0	-17,267	-100%	$4.36	Q4 2025
31 Dec 2025	call		-0%	$0	0	-24,100	-100%	$4.36	Q4 2025
30 Sep 2025		0%	-0%	$78,220	17,267	-61,004	-78%	$4.53	Q3 2025
30 Sep 2025	call	0%	+0%	$109,173	24,100	+24,100	NEW	$4.53	Q3 2025
30 Jun 2025		0%	+0%	$168,283	78,271	+78,271	NEW	$2.15	Q2 2025
30 Jun 2025	call		-0%	$0	0	-6,100	-100%	$4.36	Q2 2025
30 Jun 2025	put		-0%	$0	0	-7,600	-100%	$4.36	Q2 2025
31 Mar 2025			-0%	$0	0	-149,071	-100%	$4.36	Q1 2025
31 Mar 2025	call	0%	-0%	$26,657	6,100	-3,500		$4.37	Q1 2025
31 Mar 2025	put	0%	-0%	$33,212	7,600	-2,600		$4.37	Q1 2025
31 Dec 2024		0%	+0%	$696,162	149,071	+125,537	+533%	$4.67	Q4 2024
31 Dec 2024	call	0%	-0%	$44,832	9,600	-13,600	-59%	$4.67	Q4 2024
31 Dec 2024	put	0%	+0%	$47,634	10,200	+4,200	+70%	$4.67	Q4 2024
30 Sep 2024		0%	-0%	$165,209	23,534	-102,256	-81%	$7.02	Q3 2024
30 Sep 2024	call	0%	0%	$162,864	23,200	+200	+0.87%	$7.02	Q3 2024
30 Sep 2024	put	0%	+0%	$42,120	6,000	+1,870	+45%	$7.02	Q3 2024
30 Jun 2024		0%	+0%	$862,919	125,790	+125,790	NEW	$6.86	Q2 2024
30 Jun 2024	call	0%	+0%	$157,780	23,000	+23,000	NEW	$6.86	Q2 2024
30 Jun 2024	put	0%	+0%	$28,332	4,130	+4,130	NEW	$6.86	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.